News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Results>CSPC PHARMA Annual NP Sags 10.3%; Final DPS Adds to HKD0.15
CSPC PHARMA (01093.HK) announced its results for 2025, reporting revenue of RMB26.006 billion, down 10.4% YoY. Profit attributable to shareholders was RMB3.882 billion, down 10.3% ...
Reset
Send
The window will close in 5 seconds
<Results>CSPC PHARMA Annual NP Sags 10.3%; Final DPS Adds to HKD0.15
Close
Recommend
14
Positive
21
Negative
15
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

CSPC PHARMA (01093.HK)  +0.090 (+0.936%)    Short selling $314.42M; Ratio 92.374%   announced its results for 2025, reporting revenue of RMB26.006 billion, down 10.4% YoY. Profit attributable to shareholders was RMB3.882 billion, down 10.3% YoY, with an EPS of RMB0.3398.

Dividend History
Announce DateEventParticular
2025/11/203rd QuarterlyNo Dividend
2025/08/22InterimD:HKD 0.1400
2025/05/291st QuarterlyNo Dividend
2025/03/28FinalD:HKD 0.1000

A final DPS of HKD0.15 was declared, compared to HKD0.10 in the same period last year. Including the interim DPS of HKD0.14, the total annual DPS was HKD0.29, up 11.5% YoY.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.